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OBJECTIVES: To study the prevalence of renal failure in
a large sample of type 2 diabetes patients in Belgium and
to compare the results with the data of the Belgian ESRD
registry. METHODS: A total of 5355 patients, 2530
males and 2825 females, suffering from type 2 diabetes
and treated with oral antidiabetic drugs were recruited
from the patient ﬁles of 345 Belgian general practition-
ers. Age, gender, body height, body weight, and serum
creatinine were recorded. Renal function was calculated
using a BMI-corrected Cockroft-Gault formula and the
abbreviated MDRD formula. Annual incidence of dia-
betics starting renal replacement therapy was retrieved
from the Belgian national ESRD registry and diabetes
prevalence data from the Scientiﬁc Institute of Public
Health. RESULTS: The mean age was 68 years in females
and 64 years in males. The mean body weight was 76.01
kg in females and 84.64kg in males. The mean serum cre-
atinine was 1.04mg/dl (range: 0.5–3.0mg/dl) in females
and 1.14mg/dl (range: 0.5–10.2mg/dl) in males. Serum
creatinine levels had a tendency to rise, both in females
and males, from the age of 60 years. Renal function
showed a tendency to decrease with age, regardless of the
method of calculation. If we compare these results with
those found in a Belgian study of the general population,
we observed that the 3rd percentile of the renal function
estimate in diabetics was almost identical to that of 
the general population. The annual incidence of ESRD
among diabetics type 2 is 23 per million inhabitants.
Given a prevalence of diabetes of 2.6%, the annual inci-
dence of ESRD can be calculated as 0.088%. CONCLU-
SIONS: Apparently, there is no excess renal failure in the
diabetes population and the decrease in renal function
with advancing age is identical in both populations.
ESRD among diabetics type 2 is rare.
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THE IMPACT ON GLYCEMIC CONTROL OF
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OBJECTIVES: Diabetes Mellitus (DM) is a major health
care issue potentially causing prolonged ill health and pre-
mature death. Good adherence to prescribed diabetic
regimen is important to prevent complications but it
needs supports from a variety of health care profession-
als. This study was to explore the non-compliance proﬁle
of diabetic patients and to evaluate the clinical beneﬁts
by a pharmacist-managed diabetes clinic on the degree of
glycemic control through the provision of diabetic infor-
mation and the implementation of a drug compliance
enhancement program for the non-compliant diabetic
patients. METHODS: Patients with poor medication
compliance were recruited to receive three counseling 
sessions carried out by a hospital pharmacist. The base-
line levels of compliance and hemoglobin A1C (HbA1C)
were documented. The responsibility of the pharmacist 
in the clinic was to educate all patients individually
regarding diabetes and its complications and on the
proper use of their medicines. Patients were reassessed
and reinforced on their levels of compliance and medica-
tion knowledge during the subsequent visits. The primary
outcome measurement was the change in HbA1C over 
the 12-month study period. RESULTS: Ninety-ﬁve
patients were recruited during the 12-month study period
with 91 patients completed the study. Improvement of
HbA1C was observed as compared with the ﬁrst clinic
visit to the ﬁnal clinic visit (7.43, b 1.57% to 7.15, b
1.33%, p < 0.005). The mean compliance level improved
signiﬁcantly from 41.3% to 97.8% (p < 0.005). CON-
CLUSION: The study suggested that pharmacist-
managed compliance clinic for non-compliant diabetic
patients was effective and had a clinical impact on the
glycemic control of patients. Pharmacist can play an
important role in implementing and monitoring diabetic
therapy along with the multidisciplinary team effort in
diabetes management.
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OBJECTIVES: The objectives were to assess whether
rapid transitioning in newly diagnosed type II diabetics
from diet and exercise to insulin results in better blood
glucose control as measured by HbA1C and reduced dia-
betes-related complications. METHOD: We used longi-
tudinal data from IMS Mediplus-Germany for newly
diagnosed type II diabetics between June 1993 and May
2001 with at least two HbA1C readings. Patients with
complications at baseline were excluded. Treatment was
categorized as diet and exercise, sulfonylureas, antihy-
perglycemic drug combinations, insulin or insulin plus
another agent. Modiﬁcations to treatment were tracked
and rapid use of insulin was either initial insulin use or
immediate change from diet and exercise to insulin. Area
under the curve (AUC) for HbA1C was calculated and
